Calcium, a vital mineral, plays a critical role in maintaining skeletal health. Its importance extends beyond the formation of healthy bones and teeth, as it is also essential for muscle contraction, blood clotting, and nerve function. This article aims to elucidate the significant role of calcium in bone metabolism and its implications for clinical practice.
Approximately 99% of the body's calcium is stored in the bones and teeth, where it supports their structure and functionality. Bone metabolism is a continuous process of bone formation and resorption, which is regulated by calcium. The balance between these processes is essential for maintaining bone health. Any disruption in this balance can lead to bone diseases such as osteoporosis and rickets.
Calcium homeostasis, the balance of calcium levels in the body, is primarily regulated by three hormones: parathyroid hormone, calcitonin, and vitamin D. These hormones work together to control the absorption, excretion, and storage of calcium. Any disruption in the function of these hormones can lead to abnormal bone metabolism and subsequently, bone disease.
Understanding the role of calcium in bone metabolism is crucial for clinicians. It aids in the diagnosis and treatment of bone diseases and helps guide dietary recommendations. Moreover, it can also influence the development of therapeutic strategies for diseases related to calcium imbalance. Therefore, a comprehensive understanding of calcium metabolism is essential for optimal patient care.
In conclusion, calcium plays a pivotal role in bone metabolism and overall health. Its importance extends beyond bone health, influencing various physiological processes. A profound understanding of calcium metabolism can significantly enhance clinical practice, contributing to improved patient outcomes and the development of effective therapeutic strategies.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation